Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Cash from Investing Activities: 2013-2025

Historic Cash from Investing Activities for Fortress Biotech (FBIO) over the last 12 years, with Sep 2025 value amounting to $2.9 million.

  • Fortress Biotech's Cash from Investing Activities was N/A to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.9 million, marking a year-over-year change of. This contributed to the annual value of -$15.0 million for FY2024, which is 613.27% down from last year.
  • As of Q3 2025, Fortress Biotech's Cash from Investing Activities stood at $2.9 million, which was down 52.84% from $6.1 million recorded in Q2 2025.
  • In the past 5 years, Fortress Biotech's Cash from Investing Activities registered a high of $53.4 million during Q4 2021, and its lowest value of -$21.3 million during Q1 2022.
  • Moreover, its 3-year median value for Cash from Investing Activities was $551,000 (2023), whereas its average is -$872,750.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first soared by 3,504.79% in 2021, then plummeted by 23,709.52% in 2024.
  • Quarterly analysis of 5 years shows Fortress Biotech's Cash from Investing Activities stood at $53.4 million in 2021, then crashed by 100.73% to -$391,000 in 2022, then surged by 83.89% to -$63,000 in 2023, then slumped by 23,709.52% to -$15.0 million in 2024, then reached $2.9 million in 2025.
  • Its last three reported values are $2.9 million in Q3 2025, $6.1 million for Q2 2025, and $1.2 million during Q1 2025.